PhD

 

Professor Gil Atzmon is an Associate Professor in both University of Haifa, Israel and Albert Einstein College of Medicine, New York, USA. His research focuses on the challenging field of epigenetics and genetics in diseases, aging and longevity. The foremost focus of his research career has been the understanding of the association of the total genome, to diseases, health, performance and longevity. He has international collaborations with scientists and researchers across the world and has more than 120 scientific publications in leading scientific journals. He has been invited to present his work in numerous international scientific conferences and meetings, and has been an expert reviewer for many leading scientific journals on genetics and genomics. He also serves on the editorial board of several journals. He has remarkable experience utilizing the most advanced genomic tools and has specific expertise in molecular genetics of longevity.  He possesses the ability to combine basic genetics, genomics and bio-informatics tools to perform novel and state-of-the-art analyses that enhance our understanding of the role of genetics and age-related diseases. 

PhD

 

Professor Gil Atzmon is an Associate Professor in both University of Haifa, Israel and Albert Einstein College of Medicine, New York, USA. His research focuses on the challenging field of epigenetics and genetics in diseases, aging and longevity. The foremost focus of his research career has been the understanding of the association of the total genome, to diseases, health, performance and longevity. He has international collaborations with scientists and researchers across the world and has more than 120 scientific publications in leading scientific journals. He has been invited to present his work in numerous international scientific conferences and meetings, and has been an expert reviewer for many leading scientific journals on genetics and genomics. He also serves on the editorial board of several journals. He has remarkable experience utilizing the most advanced genomic tools and has specific expertise in molecular genetics of longevity.  He possesses the ability to combine basic genetics, genomics and bio-informatics tools to perform novel and state-of-the-art analyses that enhance our understanding of the role of genetics and age-related diseases.